JP2023543262A5 - - Google Patents

Info

Publication number
JP2023543262A5
JP2023543262A5 JP2023519180A JP2023519180A JP2023543262A5 JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5 JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023519180 A JP2023519180 A JP 2023519180A JP 2023543262 A5 JP2023543262 A5 JP 2023543262A5
Authority
JP
Japan
Prior art keywords
igg
polypeptide
substitution
canid
constant domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543262A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052338 external-priority patent/WO2022067233A2/en
Publication of JP2023543262A publication Critical patent/JP2023543262A/ja
Publication of JP2023543262A5 publication Critical patent/JP2023543262A5/ja
Pending legal-status Critical Current

Links

JP2023519180A 2020-09-28 2021-09-28 イヌ科動物抗体バリアント Pending JP2023543262A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063084241P 2020-09-28 2020-09-28
US63/084,241 2020-09-28
PCT/US2021/052338 WO2022067233A2 (en) 2020-09-28 2021-09-28 Canine antibody variants

Publications (2)

Publication Number Publication Date
JP2023543262A JP2023543262A (ja) 2023-10-13
JP2023543262A5 true JP2023543262A5 (cg-RX-API-DMAC10.html) 2024-09-27

Family

ID=78599123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519180A Pending JP2023543262A (ja) 2020-09-28 2021-09-28 イヌ科動物抗体バリアント

Country Status (17)

Country Link
US (2) US12612454B2 (cg-RX-API-DMAC10.html)
EP (1) EP4217384A2 (cg-RX-API-DMAC10.html)
JP (1) JP2023543262A (cg-RX-API-DMAC10.html)
KR (1) KR20230079148A (cg-RX-API-DMAC10.html)
CN (1) CN116438196A (cg-RX-API-DMAC10.html)
AR (1) AR123636A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021349301A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023005393A2 (cg-RX-API-DMAC10.html)
CA (1) CA3194936A1 (cg-RX-API-DMAC10.html)
CL (2) CL2023000878A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023004102A2 (cg-RX-API-DMAC10.html)
EC (1) ECSP23030271A (cg-RX-API-DMAC10.html)
IL (1) IL301413A (cg-RX-API-DMAC10.html)
MX (1) MX2023003624A (cg-RX-API-DMAC10.html)
PE (1) PE20231374A1 (cg-RX-API-DMAC10.html)
TW (1) TW202229337A (cg-RX-API-DMAC10.html)
WO (1) WO2022067233A2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297287A (en) * 2020-04-17 2022-12-01 Zoetis Services Llc Canine antibody variants
CA3194936A1 (en) * 2020-09-28 2022-03-31 Zoetis Services Llc Canine antibody variants
AU2023289332A1 (en) * 2022-06-21 2024-12-12 Zoetis Services Llc Canine antibody mutants
US20240254231A1 (en) 2023-01-20 2024-08-01 PetMedix Ltd. Therapeutic antibodies

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US5698762A (en) 1994-12-09 1997-12-16 Dauerman; Leonard Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
CA2577133A1 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US9200079B2 (en) 2004-11-12 2015-12-01 Xencor, Inc. Fc variants with altered binding to FcRn
ES2665954T3 (es) 2010-08-19 2018-04-30 Zoetis Belgium S.A. Anticuerpos anti-NGF y su uso
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
US9617334B2 (en) 2012-06-06 2017-04-11 Zoetis Services Llc Caninized anti-NGF antibodies and methods thereof
AU2014368453B2 (en) 2013-12-20 2020-04-16 Intervet International B.V. Caninized murine anti-canine PD-1 antibodies
EP3866842A4 (en) * 2018-10-18 2022-07-13 Kindred Biosciences, Inc. FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE
JP2022513653A (ja) * 2018-11-28 2022-02-09 ブリストル-マイヤーズ スクイブ カンパニー 修飾された重鎖定常領域を含む抗体
WO2020116560A1 (ja) * 2018-12-05 2020-06-11 株式会社バイカ・セラピュティクス 抗体のFc領域改変体
CN120005022A (zh) * 2019-01-03 2025-05-16 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物及使用方法
IL297287A (en) * 2020-04-17 2022-12-01 Zoetis Services Llc Canine antibody variants
US20220119513A1 (en) 2020-06-08 2022-04-21 Zoetis Services Llc Anti-tgfb antibodies and therapeutic uses thereof
CA3194936A1 (en) 2020-09-28 2022-03-31 Zoetis Services Llc Canine antibody variants

Similar Documents

Publication Publication Date Title
JP2023522029A5 (cg-RX-API-DMAC10.html)
JP2023522030A5 (cg-RX-API-DMAC10.html)
JP2021007390A5 (cg-RX-API-DMAC10.html)
JP2020506898A5 (cg-RX-API-DMAC10.html)
JP2022513025A5 (cg-RX-API-DMAC10.html)
JP2023504914A5 (cg-RX-API-DMAC10.html)
JP2020519643A5 (cg-RX-API-DMAC10.html)
Utani et al. Laminin chain assembly. Specific sequences at the C terminus of the long arm are required for the formation of specific double-and triple-stranded coiled-coil structures.
JP2020515518A5 (cg-RX-API-DMAC10.html)
JP2022502371A5 (cg-RX-API-DMAC10.html)
JP2006524039A5 (cg-RX-API-DMAC10.html)
JP2022511390A5 (cg-RX-API-DMAC10.html)
JPWO2020209318A5 (cg-RX-API-DMAC10.html)
CN118063619A (zh) 工程化的异源二聚体蛋白质
JP2011514149A5 (cg-RX-API-DMAC10.html)
JP2021533779A5 (cg-RX-API-DMAC10.html)
JP2020532285A5 (cg-RX-API-DMAC10.html)
JP2022009816A5 (cg-RX-API-DMAC10.html)
JP2007500744A5 (cg-RX-API-DMAC10.html)
JP2017113019A5 (cg-RX-API-DMAC10.html)
JP2023542737A5 (cg-RX-API-DMAC10.html)
JP2021521781A5 (cg-RX-API-DMAC10.html)
JP2024505072A5 (cg-RX-API-DMAC10.html)
JP2022513653A5 (cg-RX-API-DMAC10.html)
JP2012502969A5 (cg-RX-API-DMAC10.html)